维普中文期刊产品整合服务
183篇 您的检索式:作者名="Wadelius"
    题名 作者 年代 出处 被引量
1Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding显示文摘Guillaume Paré Niclas Eriksson Thorsten Lehr Stuart Connolly John Eikelboom Michael D. Ezekowitz Tomas Axelsson Sebastian Haertter Jonas Oldgren Paul Reilly Agneta Siegbahn Ann-Christine Syvanen Claes Wadelius Mia Wadelius Heike Zimdahl-Gelling Salim Yusu 2013Circulation2013,,13:2
2Pharmacogenetics of warfa- rin: current status and future challenges 显示文摘WADELIUS M PIRMOHAMED M 2006Pharmacogenomics J2006,9,19:1
3Warfarin pharmaco-genetics: a single VKOECI polymorphism is predictive of dose across 3 racial groups 显示文摘Limdi NA Wadelius M Cavallari L 2010Blood2010,115,18:1
4Association of warfarin dose with genes involved in its action and metab- olism显示文摘Wadelius M Chen LY Erikesson N 2007Hum Genet2007,121,1:1
5The largest prospective warfarin-treated cohort supports genetic forecasting 显示文摘WADELIUS M CHEN L Y LINDH J D 2009Blood2009,113,4:1
6Integration of genetic, clinical, and INR data to refine warfarin dosing显示文摘LENZINI P WADELIUS M KIMMEL S et 01 2010Clin Pharmacal Ther2010,87,5:1
7The largest prospective warfarin-treated cohort supports genetic forecasting显示文摘Wadelius M Chen LY Lindh JD 2009Blood2009,113,4:1
8Association of warfarin dose with genes involved in its action and metabolism显示文摘Wadelius M Chen LY Eriksson N 2007Hum Gen- et2007,121,1:1
9Common VKORC1 andGGCX polymorphisms associated with warfarin dose 显示文摘Wadelius M Chen LY Downes K 2005Pharma-cogenomics J2005,,:1
10Common VKORC1 and GGCX polymorphisms associated with warfarin dose 显示文摘WADELIUS M CHEN L Y DOWNES K 2005Pharmacogenomics J2005,5,4:1
11Integration of genetic, clinical, and INR data to refine warfarin dosing显示文摘Lenzini P Wadelius M Kimmel S 2010Clin Phar macol Ther2010,87,5:1
12Association of warfarindose with genes involved in its action and metabolism 显示文摘Wadelius M Chen LY Eriksson N 2007HumCenet2007,,:1
13Warfarin pharmaeoge- netics:a single VKORC1 polymorphism is predictive of dose across 3 racial groups显示文摘Limdi NA Wadelius M Cavallari L 2010Blood2010,115,18:1
14Pharmacogenetics of warfarin:current status and future challenges显示文摘Wadelius M Pirmohamed M 2007Pharmaeog enomics J2007,7,2:1
15The largest prospective warfarin-treated cohort supports genetic forecasting 显示文摘Wadelius M Chen LY Lindh JD 2009Blood2009,113,4:1
16The largest pro-spective Warfarin-treated cohort supports genetic forecast-ing显示文摘Wadelius M Chen LY Lindh JD 2009Blood2009,113,:1
17Common VKORC1 and GGCX polymorphisms associated with warfarin dose 显示文摘Wadelius M Chen LY Downes K 2005Pharmacog- enomics J2005,5,4:1
18Association of warfarindose with genes involved in its action and metabo-lism显示文摘Wadelius M Chen LY Eriksson N 2007Hum Genet2007,121,:1
19The largest pro- spective warfarin-treated cohort supports genetic forecast- ing显示文摘Wadelius M Chen LY Lindh JD 2009Blood2009,113,4:1
20Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy显示文摘Horne BD Lenzini PA Wadelius M 2012Thromb Haemost2012,107,2:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费